Large-Scale Antitumor Screening Based on Heterotypic 3D Tumors Using an Integrated Microfluidic Platform.

Area of Science:

• Biomedical Engineering
• Oncology
• Microfluidics

Background:

• Conventional chemotherapy screening methods lack insights into the tumor microenvironment.
• Advanced techniques are needed for 3D tumor micromanipulation, simulation, and high-throughput analysis.

Purpose of the Study:

• To introduce an integrated microfluidic platform for heterotypic 3D tumor reconstruction and antitumor screening.
• To enable massive production and dynamic analysis of 3D tumor models for drug discovery.

Main Methods:

• Development of a microfluidic platform with multiparallel components for sequential cell manipulation.
• Utilized pneumatic control for 3D tumor formation, chemical stimulation, and on-chip analysis.
• Demonstrated tumor recovery for off-chip assessment.

Main Results:

• Massive and size-uniform production of heterotypic 3D tumors with tissue-biomimetic phenotypes.
• Successful screening-like chemotherapy assessment with diverse tumor models and drugs.
• Validated the platform's versatility in large-scale tumor manipulation and analysis.

Conclusions:

• The developed microfluidic platform facilitates integrated 3D tumor micromanipulation and high-throughput antitumor screening.
• This technology offers potential applications in oncology, pharmacology, and tissue engineering for drug development.
• Provides insights into constructing high-performance microsystems for cancer research.